Table of Contents

Supplementary Materials and Methods S2
Cloning procedures S2
Fluorophore labeling S2
Sensor characterization S2
Signal recording using digital camera S3 Supplementary Tables and Figures  S4   Table S1 : Construction of sensor variants S4 Table S2 : Properties of CTX-NB-LUMABS S5 Figure S1 : SDS-PAGE analysis of purified sensor proteins S6 Figure S10: Sequences of SBs and meditopes used S16
References S17
S2
Supplementary Materials and Methods
Cloning procedures
A pET28a(+) vector containing DNA encoding HIV-NB-LUMABS-1 was ordered from GenScript. Site directed mutagenesis to change SB sequences and cysteine position as well as to introduce TAG codon were carried using the QuikChange Lightning Site-Directed Mutagenesis kit (Agilent technologies) using specific primers.
To construct pET28a(+)-CTX-NB-LUMABS, the pET28a(+) plamids encoding CTX-LUMABS which were prepared previously 1 were digested with KpnI-HF and SpeI-HF restriction enzymes. The linkers including cetuximab meditope (CTX-NB-LUMABS-1 and -2 with meditope CVFDLGTRRLRC, CTX-NB-LUMABS-3 with meditope CQFDLSTRRLKC) were then cloned into the pET28a(+) plasmids encoding NB-LUMABS by restriction-ligation approach with KpnI-HF and SpeI-HF. All cloning and mutagenesis results were confirmed by Sanger sequencing (StarSEQ).
Protein expression and purification
The pET28a plasmid encoding HIV-NB-LUMABS was transformed into E. coli BL21 (DE3). The cells were cultured in LB medium containing 30 µg/ml kanamycin at 37 °C . Protein expression was induced at an OD 600 of 0.6 using 0.1 mM IPTG at 20 °C overnight. Cells were harvested and lysed by using the Bugbuster reagent (Novagen). Sensor proteins were purified using Ni-NTA affinity chromatography followed by Strep-Tactin purification according to the manufacturer's instructions. The protein concentration was determined by measuring the absorbance at 280 nm using extinction coefficient of 39,420 M -1 cm -1 for HIV-NB-LUMABS and 28,420 M -1 cm -1 for CTX-NB-LUMABS (calculated from the protein sequence). Protein purity was confirmed by SDS-PAGE ( Figure S1 ). Purified proteins were stored at -80 o C until use.
The pET28a plasmids encoding CTX-NB-LUMABS was co-transformed into E. coli BL21 (DE3) together with a pEVOL vector encoding a tRNA/tRNA synthetase pair in order to incorporate para-azidophenylalanine (pAzF) 2 . The pEVOL vector was a gift from Peter Schultz (Addgene plasmid # 31186). Cells were cultured in 2YT medium (16 g peptone, 5 g NaCl, 10 g yeast extract per liter) containing 30 μg/mL kanamycin and 25 μg/mL chloramphenicol. Protein expression was induced using 0.1 mM IPTG and 0.2% arabinose in the presence of 1 mM pAzF (Bachem, F-3075.0001). The sensor proteins were purified as described above.
Fluorophore labeling
Purified HIV-NB-LUMABS protein was reduced with 1 mM TCEP (tris-carboxyethylphosphine) in 50 mM Tris-HCl (pH 7.4) at room temperature for 20 min. Sulfo-cyanine3 maleimide (Lumiprobe, 11380) dissolved in water (10 mg/ml) was then added in a 30-fold molar excess into the protein solution and incubated for 1 hour at room temperature followed by overnight incubation at 4 °C . Non-reacted dye was removed by using a PD10 desalting column and the conjugate was concentrated by using Amicon centrifuge filter of 10 kDa. The dye-to-protein ratio was determined by measuring absorbance at 280 nm and 553 nm and using extinction coefficients of 39,420 M -1 cm -1 and 162,000 M -1 cm -1 for the protein and dye, respectively (Table S1 ). Successful Cy3 labeling was confirmed by Q-TOF-MS ( Figure S2 ). DBCO-Sulfo-Cy3 (Jena Bioscience, CLK-A140-1) was conjugated in a 40-fold molar excess to CTX-NB-LUMABS at room temperature overnight. Excess dye was removed by using Amicon centrifuge filter of 10 kDa. The dye-to-protein ratio was determined by measuring absorbance at 280 nm and 563 nm and using extinction coefficients of 28,420 M -1 cm -1 and 151,000 M -1 cm -1 for the protein and dye, respectively. The reaction product was analyzed by Q-TOF-MS ( Figure S2 ).
Sensor characterization
Anti-HIV1-p17 antibody was obtained from Zeptometrix (clone 32/1.24.89). Cetuximab (Erbitux, Merck) was obtained via the Catherina hospital pharmacy in Eindhoven, the Netherlands. Anti-HIV1-p17 antibody titrations were performed in 100 µL PBS (pH 7.4, 1 mg/ml BSA) in PerkinElmer flat white 96-well Optiplate using a sensor concentration of 1 pM and 100 pM for anti-HIV1-p17 antibody and cetuximab antibody titrations, respectively. After incubation of sensor and antibody for 2 hours, NanoGlo substrate (Promega, N1110) was added at a final dilution of 1000-fold. Luminescence spectra were recorded between 398 nm and 653 nm on Tecan Spark 10M plate reader with a step size of 15 nm, a bandwidth of 25 nm and an integration time of 1000 ms. For blood plasma measurements, luminescence spectra were recorded using 5 nM CTX-NB-LUMABS in 200 µL pooled blood plasma obtained from Innovative Research Inc. (catalog no. IPLA-N).
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Titrations were fit to eq 1 to obtain K d values.
P1 is the maximal change in emission ratio (ER) and P2 is the emission ration in absence of antibody. Dynamic range (DR) was calculated as:
Signal recording using digital camera
Into a white 96-well plate, 200 µL PBS buffer (pH 7.4, 1 mg/ml BSA) containing 100 pM CTX-NB-LUMABS, different concentrations of cetuximab and 1 µL NanoGlo substrate was added. The plate was placed into a styrofoam box in a dark room to exclude the surrounding light. For blood plasma measurements, samples were prepared in 200 µL undiluted blood plasma with 5 nM sensor. The pictures were taken through a hole in the box using a SONY DSC-RX100 digital camera with exposure times of 10-30 s, F value of 1.8 and ISO value of 1600-6400. The images were analyzed by using the ImageJ to calculate the ratio values between the average intensity in the blue and red color channel. 
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Supplementary Tables and Figures
CTX-NB-LUMABS-1 233 ± 12 34.7 ± 3.7 194 ± 11 33.8 ± 4.9 175 ± 1 25.9 ± 1.7 429 ± 11 27. Figure S1 . SDS-PAGE analysis of purity for all sensor proteins described in this work. 
HIV-NB-LUMABS-1 M G S S H H H H H H S S G L V P R G S H
LB epitope cysteine SB2 S15 Figure S10 . DNA and corresponding amino acid sequence of HIV-NB-LUMABS-2.
HIV-NB-LUMABS-2 M G S S H H H H H H S S G L V P R G S H
M V T G Y ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGGTGACCGGCTAC R L F E E I L G S G G S G G S G G S G G S G G S G CGGCTCTTTGAAGAGATCTTAGGATCCGGTGGGTCCGGTGGTTCCGGCGGCAGTGGCGGTTCTGGAGGTAGTGGA S G G S G G S G G S G G S G G S V F T L E D F V G TCCGGGGGTTCCGGAGGCTCTGGAGGTTCAGGTGGTTCAGGGGGTAGTGTCTTCACACTCGAAGATTTCGTTGGG D W E Q T A A Y N L D Q V L E Q G G V S S L L Q N GACTGGGAACAGACAGCCGCCTACAACCTGGACCAAGTCCTTGAACAGGGAGGTGTGTCCAGTTTGCTGCAGAAT L A V S V T P I Q R I V R S G E N A L K I D I H V CTCGCCGTGTCCGTAACTCCGATCCAAAGGATTGTCCGGAGCGGTGAAAATGCCCTGAAGATCGACATCCATGTC I I P Y E G L S A D Q M A Q I E E V F K V V Y P V ATCATCCCGTATGAAGGTCTGAGCGCCGACCAAATGGCCCAGATCGAAGAGGTGTTTAAGGTGGTGTACCCTGTG D D H H F K V I L P Y G T L V I D G V T P N M L N GATGATCATCACTTTAAGGTGATCCTGCCCTATGGCACACTGGTAATCGACGGGGTTACGCCGAACATGCTGAAC Y F G R P Y E G I A V F D G K K I T V T G T L W N TATTTCGGACGGCCGTATGAAGGCATCGCCGTGTTCGACGGCAAAAAGATCACTGTAACAGGGACCCTGTGGAAC G N K I I D E R L I T P D G S M L F R V T I N S S GGCAACAAAATTATCGACGAGCGCCTGATCACCCCCGACGGCTCCATGCTGTTCCGAGTAACCATCAACAGCTCC G G G T E L D R W E K I R L R P G G S G G S G G S GGCGGGGGTACCGAACTTGACAGATGGGAGAAAATTCGCCTTAGACCAGGGGGTAGTGGGGGGTCAGGAGGCTCG G G S G G S G G S G A E A A A K E A A A K E A A A GGGGGATCAGGCGGGTCTGGAGGCTCCGGTGCAGAGGCAGCTGCGAAAGAGGCAGCAGCGAAAGAAGCCGCAGCG K E A A A K E A A A K E A A A K A G S G G S G G S AAGGAGGCTGCGGCTAAGGAGGCCGCAGCAAAAGAGGCCGCGGCAAAAGCGGGAAGCGGTGGGAGTGGCGGCTCA G G S G G S G G S G A E A A A K E A A A K E A A A GGTGGGTCTGGTGGGTCGGGAGGCTCAGGTGCGGAAGCAGCCGCAAAAGAAGCGGCGGCCAAAGAAGCTGCTGCA K E A A A K E A A A K E A A A K A G S G G S G G S AAGGAGGCAGCCGCGAAGGAAGCCGCTGCCAAAGAGGCGGCAGCTAAGGCAGGTTCTGGTGGAAGTGGTGGCTCA G G
S G G S G G S G G E L D R W E K I R L R P T S GGCGGTTCGGGCGGTAGCGGCGGGTCAGGGGGCGAGCTGGATCGCTGGGAAAAAATCCGGTTGCGCCCGACTAGT G G S G G S V T G Y R L F E K E S G G S C G G S W GGTGGTAGTGGAGGCTCCGTTACCGGCTATCGTCTGTTTGAAAAAGAGAGCGGAGGTTCGTGTGGTGGGAGTTGG S H P Q F E K * TCTCATCCACAATTTGAGAAGTAA
SBiT1
LBiT epitope SBiT2 cysteine Figure S11 . DNA and corresponding amino acid sequences of SBs and meditopes in NB-LUMABS variants. 
HIV-NB-LUMABS-4 (SBs only) SB1: V T G Y R L F E E I L GTGACCGGCTACCGGCTCTTTGAAGAGATCTTA SB2: V T G Y R L F E K I S GTTACCGGCTATCGTCTGTTTGAAAAAATAAGC
HIV-NB-LUMABS-5 (SBs only)
